These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32987103)

  • 1. Design of novel viral attachment inhibitors of the spike glycoprotein (S) of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) through virtual screening and dynamics.
    Oany AR; Mia M; Pervin T; Junaid M; Hosen SMZ; Moni MA
    Int J Antimicrob Agents; 2020 Dec; 56(6):106177. PubMed ID: 32987103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoinformatics based elucidation and designing of potential inhibitors against Plasmodium falciparum to target importin α/β mediated nuclear importation.
    Oany AR; Pervin T; Moni MA
    Infect Genet Evol; 2021 Mar; 88():104699. PubMed ID: 33385575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
    Prashantha CN; Gouthami K; Lavanya L; Bhavanam S; Jakhar A; Shakthiraju RG; Suraj V; Sahana KV; Sujana HS; Guruprasad NM; Ramachandra R
    J Mol Graph Model; 2021 Jan; 102():107769. PubMed ID: 33152616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
    Dhameliya TM; Nagar PR; Gajjar ND
    Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Severe Acute Respiratory Syndrome Coronavirus-2 inhibitors through in silico structure-based virtual screening and molecular interaction studies.
    Azad I; Khan T; Maurya AK; Irfan Azad M; Mishra N; Alanazi AM
    J Mol Recognit; 2021 Oct; 34(10):e2918. PubMed ID: 34132436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2.
    Chandel V; Sharma PP; Raj S; Choudhari R; Rathi B; Kumar D
    J Biomol Struct Dyn; 2022 Jan; 40(1):249-262. PubMed ID: 32838660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Efficacy of Selected Natural Phytochemicals against SARS-CoV-2 Spike Glycoprotein Using Structure-Based Drug Designing.
    Aloufi BH; Snoussi M; Sulieman AME
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico evaluation of natural alkaloids against the main protease and spike glycoprotein as potential therapeutic agents for SARS-CoV-2.
    Shah M; Yamin R; Ahmad I; Wu G; Jahangir Z; Shamim A; Nawaz H; Nishan U; Ullah R; Ali EA; Sheheryar ; Chen K
    PLoS One; 2024; 19(1):e0294769. PubMed ID: 38175855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual Screening of Phytochemicals by Targeting HR1 Domain of SARS-CoV-2 S Protein: Molecular Docking, Molecular Dynamics Simulations, and DFT Studies.
    Majeed A; Hussain W; Yasmin F; Akhtar A; Rasool N
    Biomed Res Int; 2021; 2021():6661191. PubMed ID: 34095308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-Based Virtual Screening, Quantum Mechanics Calculations, and Molecular Dynamics Simulation Approaches Identified Potential Natural Antiviral Drug Candidates against MERS-CoV S1-NTD.
    Bouback TA; Pokhrel S; Albeshri A; Aljohani AM; Samad A; Alam R; Hossen MS; Al-Ghamdi K; Talukder MEK; Ahammad F; Qadri I; Simal-Gandara J
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
    Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
    Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19.
    Kumar Tiwari P; Chouhan M; Mishra R; Gupta S; Chaudhary AA; Al-Zharani M; Ahmed Qurtam A; Nasr FA; Jha NK; Pant K; Kumar M; Kumar S
    Front Cell Infect Microbiol; 2024; 14():1391288. PubMed ID: 38919703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein.
    Power H; Wu J; Turville S; Aggarwal A; Valtchev P; Schindeler A; Dehghani F
    Bioorg Chem; 2022 Feb; 119():105574. PubMed ID: 34971947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
    Romeo A; Iacovelli F; Falconi M
    Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
    Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
    Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of natural compounds with anti-SARS-CoV-2 activity via inhibition of SARS-CoV-2 Mpro.
    Bharadwaj S; Dubey A; Yadava U; Mishra SK; Kang SG; Dwivedi VD
    Brief Bioinform; 2021 Mar; 22(2):1361-1377. PubMed ID: 33406222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.
    Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M
    BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design.
    Shanmugam A; Venkattappan A; Gromiha MM
    Curr Top Med Chem; 2022; 22(29):2396-2409. PubMed ID: 36330617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.